Literature DB >> 11428914

Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria.

H Nikaido1.   

Abstract

Bacteria, being unicellular, are constantly exposed to toxic compounds in their environment. Gram-negative bacteria and mycobacteria are unusually successful in surviving in the presence of toxic compounds because they combine two mechanisms of resistance. They produce effective permeability barriers, comprising the outer membrane and the mycolate-containing cell wall, on the cell surface. Further, they actively pump out drug molecules that trickle through the barrier, often utilizing multidrug efflux pumps. In Gram-negative bacteria, multidrug pumps of exceptionally wide specificity frequently interact with outer membrane channels and accessory proteins, forming multisubunit complexes that extrude drug molecules directly into the medium, bypassing the outer membrane barrier. Copyright 2001 Academic Press.

Mesh:

Substances:

Year:  2001        PMID: 11428914     DOI: 10.1006/scdb.2000.0247

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  86 in total

1.  Rv1218c, an ABC transporter of Mycobacterium tuberculosis with implications in drug discovery.

Authors:  Meenakshi Balganesh; Sanjana Kuruppath; Nimi Marcel; Sreevalli Sharma; Anju Nair; Umender Sharma
Journal:  Antimicrob Agents Chemother       Date:  2010-10-04       Impact factor: 5.191

Review 2.  Molecular basis of bacterial outer membrane permeability revisited.

Authors:  Hiroshi Nikaido
Journal:  Microbiol Mol Biol Rev       Date:  2003-12       Impact factor: 11.056

3.  Efflux of cytoplasmically acting antibiotics from gram-negative bacteria: periplasmic substrate capture by multicomponent efflux pumps inferred from their cooperative action with single-component transporters.

Authors:  Michael Palmer
Journal:  J Bacteriol       Date:  2003-09       Impact factor: 3.490

4.  Overexpression of the MtrC-MtrD-MtrE efflux pump due to an mtrR mutation is required for chromosomally mediated penicillin resistance in Neisseria gonorrhoeae.

Authors:  Wendy L Veal; Robert A Nicholas; William M Shafer
Journal:  J Bacteriol       Date:  2002-10       Impact factor: 3.490

5.  Targeting cell division: small-molecule inhibitors of FtsZ GTPase perturb cytokinetic ring assembly and induce bacterial lethality.

Authors:  Danielle N Margalit; Laura Romberg; Rebecca B Mets; Alan M Hebert; Timothy J Mitchison; Marc W Kirschner; Debabrata RayChaudhuri
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-02       Impact factor: 11.205

6.  Domain cross-talk during effector binding to the multidrug binding TTGR regulator.

Authors:  Craig Daniels; Abdelali Daddaoua; Duo Lu; Xiaodong Zhang; Juan-Luis Ramos
Journal:  J Biol Chem       Date:  2010-04-30       Impact factor: 5.157

7.  Characterization of novel Mycobacterium tuberculosis and Mycobacterium smegmatis mutants hypersusceptible to beta-lactam antibiotics.

Authors:  Anthony R Flores; Linda M Parsons; Martin S Pavelka
Journal:  J Bacteriol       Date:  2005-03       Impact factor: 3.490

Review 8.  Vacuuming the periplasm.

Authors:  Olga Lomovskaya; Maxim Totrov
Journal:  J Bacteriol       Date:  2005-03       Impact factor: 3.490

9.  Correlation between ceftriaxone resistance of Salmonella enterica serovar Typhimurium and expression of outer membrane proteins OmpW and Ail/OmpX-like protein, which are regulated by BaeR of a two-component system.

Authors:  Wensi S Hu; Pei-Chuan Li; Chao-Yin Cheng
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

10.  Identification of a novel multidrug efflux pump of Mycobacterium tuberculosis.

Authors:  Olga Danilchanka; Claudia Mailaender; Michael Niederweis
Journal:  Antimicrob Agents Chemother       Date:  2008-05-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.